Abstract: Lumbar Spine Degeneration Classification (LSDC) poses significant diagnostic challenges as radiologists manually assess each MRI scan which is time-consuming, subjective, and prone to ...

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...